Dr. Steve Shoptaw, CBAM’s Executive Director, will be joining the editorial board of Drug and Alcohol Dependence (DAD). DAD is an international journal dedicated to publishing original research, scholarly reviews, commentaries, and policy analyses in the areas of drug, alcohol, and tobacco use and dependence. Dr. Shoptaw brings expertise garnered from over 25 years conducting Phase Ib and IIa randomized clinical trials of medications and behavioral interventions for stimulant-dependent individuals. He has produced over 180 papers. Dr. Shoptaw’s expertise includes conducting carefully controlled, randomized placebo controlled clinical trials of treatments for individuals with behavioral disorders that present significant difficulties in complying with research protocols. Dr. Shoptaw’s work at the intersection of HIV transmission and substance use disorders includes serving as being an elected member of the HIV Prevention Trials Network (HPTN) Executive Committee, and site Principal Investigator and CRS-leader for multiple HPTN protocols. Dr. Shoptaw also conducts international research with the Department of Psychiatry at the University of Cape Town, where he is an Honorary Professor.


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.